ValuentumAd

Official PayPal Seal

Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Latest Valuentum Commentary

Feb 16, 2018
Dividend Increases/Decreases for the Week Ending February 16
Let's take a look at companies that raised/lowered their dividend this week.
Jan 2, 2018
2018 Healthcare and Biotech Outlook
Image Source: Global Panorama. 2017 will undoubtedly go down as one of the most fabulous years for the stock market, and while we continue to warn of the dangers associated with the market continuing to trade at lofty valuations, we are intrigued by the outlook for big cap pharma and biotech in the near term. Changes in the US tax laws will likely have a profound impact on the industry.
Nov 19, 2017
Dividend Increases/Decreases for the Week Ending November 17
Let's take a look at companies raising/lowering their dividends this week.
Aug 20, 2017
Dividend Increases/Decreases for the Week Ending August 18
Let's take a look at companies raising/lowering their dividends this week.
May 29, 2017
Dividend Increases/Decreases for the Week Ending May 26
Let's take a look at companies that raised/lowered their dividends this week.
Nov 21, 2016
Dividend Increases/Decreases for the Week Ending November 18
Let's take a look at companies raising/lowering their dividends this week.
Apr 18, 2016
Dividend Increases/Decreases for the Week Ending April 15
Image Source: Mike Mozart. Let's take a look at companies raising/lowering their dividends this week.


Latest Press Releases



The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.